Neuroendocrine Dysregulation in Irritable Bowel Syndrome Patients: A Pilot Study = Neuroendocrine Dysregulation in Irritable Bowel Syndrome Patients: A Pilot Study

다국어 초록 (Multilingual Abstract)

Background/Aims
Irritable bowel syndrome (IBS) is a multifactorial disorder, involving dysregulation of brain-gut axis. Our aim was to evaluate the neuroendocrine activity in IBS.
Methods
Thirty IBS and 30 healthy volunteers were enrolled. Psychological symptoms were evaluated by questionnaires. Urinary 5-hydroxyindoleacetic acid, plasma serotonin (5-hydroxytryptamine, 5-HT), endothelin, and neuropeptide Y (NPY), and plasma and urinary cortisol levels were evaluated. Fourteen IBS subjects underwent microneurography to obtain multiunit recordings of efferent postganglionic muscle sympathetic nerve activity (MSNA).
Results
Prevalent psychological symptoms in IBS were maladjustment (60%), trait (40%) and state (17%) anxiety, obsessive compulsive-disorders (23%), and depressive symptoms (23%). IBS showed increased NPY (31.9 [43.7] vs 14.8 [18.1] pmol/L, P = 0.006), 5-HT (214.9 [182.6] vs 141.0 [45.5] pg/mL, P = 0.010), and endothelin [1.1 [1.4] vs 2.1 [8.1] pg/mL, P = 0.054], compared to healthy volunteers. Moreover, plasma NPY, endothelin, cortisol and 5-HT, and urinary 5-hydroxyindoleacetic acid were associated with some psychological disorders (P ≤ 0.05). Despite a similar resting MSNA, after cold pressor test, IBS showed a blunted increase in MSNA burst frequency (+4.1 vs +7.8 bursts/min, P = 0.048; +30.1% vs +78.1%, P = 0.023). Baseline MSNA tended to be associated with urinary cortisol (ρ = 0.557, P = 0.059). Moreover, changes in heart rate after mental stress were associated with urinary cortisol (ρ = 0.682, P = 0.021) and changes in MSNA after mental stress were associated with plasma cortisol (ρ = 0.671, P = 0.024).”
Conclusion
Higher concentrations of endothelin, NPY, and 5-HT were found to be associated with some psychological disorders in IBS patients together with an altered cardiovascular autonomic reactivity to acute stressors compared to healthy volunteers.
(J Neurogastroenterol Motil 2017;23:428-434)

참고문헌 (Reference)

1 Straub RH, "Uncoupling of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis in inflammatory bowel disease?" 126 : 116-125, 2002

2 Sternberg EM, "The stress response and the regulation of inflammatory disease" 117 : 854-866, 1992

3 Dodt C, "The stress hormone adrenocorticotropin enhances sympathetic outflow to the muscle vascular bed in humans" 16 : 195-201, 1998

4 von Boyen G, "The enteric glia and neurotrophic factors" 44 : 985-990, 2006

5 Bruno RM, "Sympathetic regulation of vascular function in health and disease" 3 : 284-, 2012

6 Stasi C, "Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome" 18 : 613-621, 2014

7 Weitz G, "Relationship between metabolic parameters, blood pressure, and sympathoendocrine function in healthy young adults with low birth weight" 113 : 444-450, 2005

8 Lydiard RB, "Prevalence of psychiatric disorders in patients with irritable bowel syndrome" 34 : 229-234, 1993

9 Bearcroft CP, "Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome : a pilot study" 42 : 42-46, 1998

10 Forbes SC, "Peptide YY, neuropeptide Y and corticotrophin-releasing factor modulate gastrointestinal motility and food intake during acute stress" 26 : 1605-1614, 2014

11 Arzubiaga C, "Neuropeptide Y, a putative cotransmitter in noradrenergic neurons, induces mast cell degranulation but not prostaglandin D2 release" 87 : 88-93, 1991

12 Stasi C, "Neuroendocrine markers and psychological features in patients with irritable bowel syndrome" 28 : 1203-1208, 2013

13 Hjemdahl P, "Muscle sympathetic activity and norepinephrine release during mental challenge in humans" 257 (257): E654-E664, 1989

14 Kaplan HI, "Kaplan and Sadock’s synopsis of psychiatry: behavioral sciences, clinical psychiatry" Williams & Wilkins Co 1998

15 Harris LA, "Irritable bowel syndrome and chronic constipation: emerging drugs, devices, and surgical treatments" 8 : 282-290, 2006

16 Bruno RM, "Interactions between sympathetic nervous system and endogenous endothelin in patients with essential hypertension" 57 : 79-84, 2011

17 Fukudo S, "Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome" 42 : 845-849, 1998

18 Longstreth GF, "Functional bowel disorders" 130 : 1480-1491, 2006

19 Tadayuki Oshima, "Epidemiology of Functional Gastrointestinal Disorders in Japan and in the World" 대한소화기 기능성질환∙운동학회 21 (21): 320-329, 2015

20 Nowicki PT, "Endothelin-1 in human intestine resected for necrotizing enterocolitis" 146 : 805-810, 2005

21 Victor RG, "Effects of the cold pressor test on muscle sympathetic nerve activity in humans" 9 : 429-436, 1987

22 Rae GA, "Effects and mechanisms of action of endothelins on non-vascular smooth muscle of the respiratory, gastrointestinal and urogenital tracts" 55 : 1-46, 1995

23 Bruno RM, "Effect of acute administration of vitamin C on muscle sympathetic activity, cardiac sympathovagal balance, and baroreflex sensitivity in hypertensive patients" 96 : 302-308, 2012

24 Camilleri M, "Brain-gut axis : from basic understanding to treatment of IBS and related disorders" 54 : 446-453, 2012

25 Salvioli B, "Autonomic nervous system dysregulation in irritable bowel syndrome" 27 : 423-430, 2015

26 Waring WS, "Autonomic cardiovascular responses are impaired in women with irritable bowel syndrome" 38 : 658-663, 2004

27 Stasi C, "Altered neuro-endocrine-immune pathways in the irritable bowel syndrome : the top-down and the bottom-up model" 47 : 1177-1185, 2012

28 Middlekauff HR, "Acupuncture effects on reflex responses to mental stress in humans" 280 : R1462-R1468, 2001

29 Bertolotti G, "A computerized approach to cognitive behavioural assessment: an introduction to CBA-2.0 primary scales" 21 : 21-27, 1990